Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05055_nanopub.RAlBpr-VdnQXU9B2NsF14snlSWGExCuK66geUHUFu4xuQ#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05055 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05055 label "RG2417 [drugbank:DB05055]" assertion.
- drugbank:DB05055 seeAlso DB05055 assertion.
- drugbank:DB05055 description "RG2417 is a proprietary formulation of uridine, a biological compound essential for the synthesis of DNA and RNA, the basic hereditary material found in all cells, and numerous other factors essential for cell metabolism. Uridine is synthesized by the mitochondria, the power plant of the human cell responsible for energy metabolism. The rationale for uridine therapy in neuropsychiatric disorders is supported by preclinical and clinical research. Recent reports indicate that certain genes that encode for mitochondrial proteins are significantly down regulated in the brains of bipolar patients. This new insight suggests that the symptoms of bipolar disorder may be linked to dysregulation of energy metabolism of the brain." assertion.
- drugbank:DB05055 identifier "drugbank:DB05055" assertion.
- drugbank:DB05055 title "RG2417" assertion.
- drugbank:DB05055 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05055 drugbank_vocabulary:drugbank-id "DB05055" assertion.
- drugbank:DB05055 bio2rdf_vocabulary:x-identifiers.org DB05055 assertion.
- drugbank:DB05055 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05055" assertion.
- drugbank:DB05055 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05055 bio2rdf_vocabulary:identifier "DB05055" assertion.